These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10423609)

  • 41. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
    Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of quinapril in the elderly hypertensive patient.
    Forette B; Koen R; Vicaut E
    Am Heart J; 1992 May; 123(5):1426-32. PubMed ID: 1575170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.
    Munger MA; Chance M; Nair R; Prescott AW; Nara AR; Simonson MS; Green JA; Posvar EL
    J Clin Pharmacol; 1992 Jan; 32(1):70-6. PubMed ID: 1740540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overall tolerance and safety of quinapril in clinical trials.
    Frank GJ; Knapp LE; McLain RW
    Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
    Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
    Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of captopril and ibopamine in mild to moderate heart failure.
    Dohmen HJ; Dunselman PH; Poole-Wilson PA
    Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
    Gadzhiev AN
    Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
    Jondeau G; Dib JC; Dubourg O; Bourdarias JP
    Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M; Koch B; Jansen T; Fox A; Loh I
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):769-73. PubMed ID: 8961074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The treatment of moderate to severe hypertension with ACE inhibitors.
    Goldstein RJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
    Holt P; Najm J; Sowton E
    Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension.
    Palatini P; Bongiovi S; Mario L; Mormino P; Raule G; Pessina AC
    Eur J Clin Pharmacol; 1995; 48(6):435-9. PubMed ID: 8582460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular performance after intravenous infusion of captopril in patients with congestive heart failure.
    Arcidiacono G; Asmundo GO; Battaglia E; Bordignon E; Calogero AE; Cuscunà S; Floridia S; Vigo G; Ossino AM; Gurgone G
    Minerva Cardioangiol; 1995; 43(11-12):481-4. PubMed ID: 8710137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the safety and efficacy of delapril with captopril in outpatients with congestive heart failure.
    Fuchs W
    Am J Cardiol; 1995 Jun; 75(18):29F-36F. PubMed ID: 7778531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the safety and efficacy of delapril with enalapril in patients with congestive heart failure.
    Rengo F; Acanfora D; Furgi G; Papa A; Nicolino A; Picone C; Vitale DF; Rengo C
    Am J Cardiol; 1995 Jun; 75(18):25F-28F. PubMed ID: 7778530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.